Which has grown faster, GMED or IBRX?

Over the past five years, IBRX grew revenue faster — GMED at a 27.65% CAGR versus IBRX at 202.97%.

Is GMED or IBRX more profitable?

GMED runs the higher net margin — GMED at 17.03% versus IBRX at -598.56%.

How have GMED and IBRX total returns compared?

Over the past 10 years, GMED delivered 12.82% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Globus Medical, Inc. (GMED) vs ImmunityBio, Inc. (IBRX)

A side-by-side comparison of Globus Medical, Inc. and ImmunityBio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GMED

Globus Medical, Inc.

$10.31B

$76.43HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

IBRX

ImmunityBio, Inc.

$10.15B

$9.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — GMED vs IBRX

growth of $100 · dividends reinvested · last 10y

GMED +239.1% (+13.0%/yr)IBRX +41.8% (+3.6%/yr)GMED compounded faster over this window

GMED IBRX

GMED vs IBRX: by the numbers

•GMED is the larger company ($10.31B vs $10.15B market cap).
•GMED is profitable (17.03% net margin) while IBRX runs a net loss (-598.56%).
•IBRX grew revenue faster over the past five years (202.97% vs 27.65% CAGR).

Metrics side by side

Valuation

Metric	GMED	IBRX
P/E ratio	19.65	N/A
Forward P/E	15.28	N/A
PEG ratio	0.63	N/A
P/S ratio	3.28	61.21
P/B ratio	2.16	N/A
EV / EBITDA	10.62	N/A
FCF yield	7.28%	N/A

Profitability

Metric	GMED	IBRX
Gross margin	68.55%	94.63%
Operating margin	20.75%	-226.00%
Net margin	17.03%	-598.56%
ROE	11.23%	N/A
ROIC	10.49%	-45.63%

Growth (annualized)

Metric	GMED	IBRX
Revenue CAGR (5Y)	27.65%	202.97%
EPS CAGR (5Y)	30.79%	N/A
FCF CAGR (5Y)	29.93%	N/A
Total return CAGR (5Y)	-0.44%	0.39%

Frequently asked

Which has grown faster, GMED or IBRX?: Over the past five years, IBRX grew revenue faster — GMED at a 27.65% CAGR versus IBRX at 202.97%.
Is GMED or IBRX more profitable?: GMED runs the higher net margin — GMED at 17.03% versus IBRX at -598.56%.
How have GMED and IBRX total returns compared?: Over the past 10 years, GMED delivered 12.82% and IBRX delivered 2.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full GMED analysis Full IBRX analysis Interactive comparison tool

Dig into the metrics

Globus Medical P/E ratio Globus Medical ROE ImmunityBio ROE Globus Medical operating margin ImmunityBio operating margin Globus Medical revenue growth ImmunityBio revenue growth Globus Medical free cash flow ImmunityBio free cash flow

Globus Medical & ImmunityBio appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.